{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:42:22Z","timestamp":1794246142842,"version":"4.9.0"},"reference-count":67,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"unspecified","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2020,4,15]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Drug-resistant tuberculosis burdens fragile health systems in sub-Saharan Africa (SSA), complicated by high prevalence of HIV. Several African countries reported large gaps between estimated incidence and diagnosed or treated cases. Our review aimed to identify barriers and facilitators influencing diagnosis and treatment for drug-resistant tuberculosis (DR-TB) in SSA, which is necessary to develop effective strategies to find the missing incident cases and improve quality of care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using an integrative design, we reviewed and narratively synthesised qualitative, quantitative and mixed-methods studies from nine electronic databases: Medline, Global Health, CINAHL, EMBASE, Scopus, Web of Science, International Journal of Tuberculosis and Lung Disease, PubMed and Google Scholar (January 2006 to June 2019).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 3181 original studies identified, 55 full texts were screened, and 29 retained. The studies included were from 6 countries, mostly South Africa. Barriers and facilitators to DR-TB care were identified at the health system and patient levels. Predominant health system barriers were laboratory operational issues, provider knowledge and attitudes and information management. Facilitators included GeneXpert MTB\/RIF (Xpert) diagnosis and decentralisation of services. At the patient level, predominant barriers were patients being lost to follow-up or dying due to lengthy diagnostic and treatment delays, negative public sector care perceptions, family, work or school commitments and using private sector care. Some patient-level facilitators were HIV positivity and having more symptoms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Case detection and treatment for DR -TB in SSA currently relies on individual patients presenting voluntarily to the hospital for care. Specific interventions targeting identified barriers may improve rates and timeliness of detection and treatment.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2019-002280","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T02:05:11Z","timestamp":1593741911000},"page":"e002280","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":70,"title":["Factors influencing diagnosis and treatment initiation for multidrug-resistant\/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review"],"prefix":"10.1136","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0779-570X","authenticated-orcid":false,"given":"Charity","family":"Oga-Omenka","sequence":"first","affiliation":[{"name":"\u00c9cole de sant\u00e9 publique de l\u2019Universit\u00e9 de Montr\u00e9al (ESPUM), Montr\u00e9al, Quebec, Canada"},{"name":"Centre de recherche en sant\u00e9 publique, Universit\u00e9 de Montr\u00e9al (CReSP), Montr\u00e9al, Quebec, Canada"},{"name":"McGill International TB Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhee","family":"Tseja-Akinrin","sequence":"additional","affiliation":[{"name":"Azhee Akinrin Consulting, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulami","family":"Sen","sequence":"additional","affiliation":[{"name":"McGill International TB Centre, Montreal, Quebec, Canada"},{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5966-6702","authenticated-orcid":false,"given":"Muriel","family":"Mac-Seing","sequence":"additional","affiliation":[{"name":"\u00c9cole de sant\u00e9 publique de l\u2019Universit\u00e9 de Montr\u00e9al (ESPUM), Montr\u00e9al, Quebec, Canada"},{"name":"Centre de recherche en sant\u00e9 publique, Universit\u00e9 de Montr\u00e9al (CReSP), Montr\u00e9al, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderonke","family":"Agbaje","sequence":"additional","affiliation":[{"name":"Institute of Human Virology, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick","family":"Menzies","sequence":"additional","affiliation":[{"name":"McGill International TB Centre, Montreal, Quebec, Canada"},{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Zarowsky","sequence":"additional","affiliation":[{"name":"\u00c9cole de sant\u00e9 publique de l\u2019Universit\u00e9 de Montr\u00e9al (ESPUM), Montr\u00e9al, Quebec, Canada"},{"name":"Centre de recherche en sant\u00e9 publique, Universit\u00e9 de Montr\u00e9al (CReSP), Montr\u00e9al, Quebec, Canada"},{"name":"School of Public Health, University of the Western Cape, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"2025073014385379000_5.7.e002280.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60410-2"},{"key":"2025073014385379000_5.7.e002280.2","unstructured":"WHO . Global tuberculosis report 2019, 2019."},{"key":"2025073014385379000_5.7.e002280.3","unstructured":"UN . UN General Assembly High-Level Meeting on the fight against tuberculosis. New York: United Nations, 2018."},{"key":"2025073014385379000_5.7.e002280.4","unstructured":"Osborn D , Cutter A , Ullah F . Universal sustainable development goals. in Understanding the transformational Challenge for Developed Countries. Report of Study by Stakeholder Forum, 2015."},{"key":"2025073014385379000_5.7.e002280.5","unstructured":"WHO . Gear up to end TB: introducing the end TB strategy. World Health Organization, 2015."},{"key":"2025073014385379000_5.7.e002280.6","unstructured":"UN . UN General Assembly, Seventy-third session, in 18th plenary meeting. New York: United Nations, 2018."},{"key":"2025073014385379000_5.7.e002280.7","doi-asserted-by":"crossref","unstructured":"Cox HS et al . Impact of decentralized care and the Xpert MTB\/RIF test on rifampicin-resistant tuberculosis treatment initiation in Khayelitsha, South Africa. Open Forum Infectious Diseases 2015;2.","DOI":"10.1093\/ofid\/ofv014"},{"key":"2025073014385379000_5.7.e002280.8","first-page":"420","article-title":"Community-Based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa","volume":"14","author":"Heller","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073014385379000_5.7.e002280.9","doi-asserted-by":"publisher","DOI":"10.1136\/adc.88.12.1106"},{"key":"2025073014385379000_5.7.e002280.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062034"},{"key":"2025073014385379000_5.7.e002280.11","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0834"},{"key":"2025073014385379000_5.7.e002280.12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.5588\/ijtld.17.0230","article-title":"Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis","volume":"21","author":"Boyd","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073014385379000_5.7.e002280.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2005.03621.x"},{"key":"2025073014385379000_5.7.e002280.14","unstructured":"STROBE Statement . STROBE Statement - Checklist of items that shouldbe included in reports of observational studies, 2007. Available: https:\/\/www.strobe-statement.org\/fileadmin\/Strobe\/uploads\/checklists\/STROBE_checklist_v4_combined.pdf [Accessed 15 Sep 2018]."},{"key":"2025073014385379000_5.7.e002280.15","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzm042"},{"key":"2025073014385379000_5.7.e002280.16","doi-asserted-by":"crossref","unstructured":"Hong QN et al . The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers. Education for Information 2018:1\u20137.","DOI":"10.3233\/EFI-180221"},{"key":"2025073014385379000_5.7.e002280.17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"2025073014385379000_5.7.e002280.18","doi-asserted-by":"publisher","DOI":"10.1186\/1475-9276-12-18"},{"key":"2025073014385379000_5.7.e002280.19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00520-017-3964-5","article-title":"Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review","volume":"26","author":"Clifford","year":"2018","journal-title":"Supportive Care in Cancer"},{"key":"2025073014385379000_5.7.e002280.20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005641","article-title":"Nonadherence to antihypertensive drugs: a systematic review and meta-analysis","volume":"96","author":"Abegaz","year":"2017","journal-title":"Medicine"},{"key":"2025073014385379000_5.7.e002280.21","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-013-0106-8"},{"key":"2025073014385379000_5.7.e002280.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2011.07.002"},{"key":"2025073014385379000_5.7.e002280.23","first-page":"1","article-title":"Barriers and delays in tuberculosis diagnosis and treatment services: does gender matter?","volume":"2014","author":"Yang","year":"2014","journal-title":"Tuberc Res Treat"},{"key":"2025073014385379000_5.7.e002280.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008103"},{"key":"2025073014385379000_5.7.e002280.25","unstructured":"WHO . Everybody's business-strengthening health systems to improve health outcomes: who's framework for action, 2007."},{"key":"2025073014385379000_5.7.e002280.26","doi-asserted-by":"crossref","unstructured":"Andersen R , Newman JF . Societal and individual determinants of medical care utilization in the United States. The Milbank Quarterly 2005;83.","DOI":"10.1111\/j.1468-0009.2005.00428.x"},{"key":"2025073014385379000_5.7.e002280.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix128"},{"key":"2025073014385379000_5.7.e002280.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212421","article-title":"Routine surveillance for the identification of drug resistant tuberculosis in Tanzania: a cross-sectional study of stakeholders' perceptions","volume":"14","author":"Doulla","year":"2019","journal-title":"PLoS One"},{"key":"2025073014385379000_5.7.e002280.29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.7196\/SAMJ.2017.v107i6.12260","article-title":"When students become patients: TB disease among medical undergraduates in Cape town, South Africa","volume":"107","author":"Van der Westhuizen","year":"2017","journal-title":"S Afr Med J"},{"key":"2025073014385379000_5.7.e002280.30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ijid.2019.02.007","article-title":"Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain\n                  \u00ae\n                Line Probe Assay in Southern provinces, Zimbabwe","volume":"81","author":"Timire","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2025073014385379000_5.7.e002280.31","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-018-3235-7","article-title":"Assessment of GeneXpert GxAlert platform for multi-drug resistant tuberculosis diagnosis and patients' linkage to care in Tanzania","volume":"11","author":"Mnyambwa","year":"2018","journal-title":"BMC Res Notes"},{"key":"2025073014385379000_5.7.e002280.32","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-015-1145-0"},{"key":"2025073014385379000_5.7.e002280.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215542","article-title":"Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria- a retrospective cohort study","volume":"14","author":"Oga-Omenka","year":"2019","journal-title":"PLoS One"},{"key":"2025073014385379000_5.7.e002280.34","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.5588\/ijtld.17.0372","article-title":"Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert\u00ae MTB\/RIF","volume":"21","author":"Mohr","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073014385379000_5.7.e002280.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-3762-x","article-title":"Impact of Xpert MTB\/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa","volume":"18","author":"Evans","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2025073014385379000_5.7.e002280.36","doi-asserted-by":"crossref","unstructured":"Moyo S , J Furin J , Hughes J , et al . Outcomes in adolescents undergoing treatment for drug-resistant tuberculosis in Cape town, South Africa, 2008-2013. Arch Pediatr Infect Dis 2014;2.doi:10.5812\/pedinfect.17934","DOI":"10.5812\/pedinfect.17934"},{"key":"2025073014385379000_5.7.e002280.37","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.14.0653"},{"key":"2025073014385379000_5.7.e002280.38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065421","article-title":"Time to treatment and patient outcomes among TB suspects screened by a single point-of-care Xpert MTB\/RIF at a primary care clinic in Johannesburg, South Africa","volume":"8","author":"Hanrahan","year":"2013","journal-title":"PLoS One"},{"key":"2025073014385379000_5.7.e002280.39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103328","article-title":"A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert\u00ae MTB\/RIF-Based algorithms in a routine operational setting in Cape town","volume":"9","author":"Naidoo","year":"2014","journal-title":"PLoS One"},{"key":"2025073014385379000_5.7.e002280.40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5588\/pha.12.0024","article-title":"Why do child contacts of multidrug-resistant tuberculosis not come to the assessment clinic?","volume":"2","author":"Zimri","year":"2012","journal-title":"Public Health Action"},{"key":"2025073014385379000_5.7.e002280.41","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-14-442","article-title":"Effects of introducing Xpert MTB\/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa","volume":"14","author":"Dlamini-Mvelase","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2025073014385379000_5.7.e002280.42","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6963-13-268","article-title":"Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng\/South Africa: a descriptive questionnaire-based study","volume":"13","author":"Nkosi","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"2025073014385379000_5.7.e002280.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002238"},{"key":"2025073014385379000_5.7.e002280.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3237-z","article-title":"Variability in distribution and use of tuberculosis diagnostic tests in Kenya: a cross-sectional survey","volume":"18","author":"Oliwa","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2025073014385379000_5.7.e002280.45","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-2114-x","article-title":"Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study","volume":"17","author":"Bieh","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2025073014385379000_5.7.e002280.46","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5588\/ijtld.17.0491","article-title":"Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa","volume":"22","author":"Kweza","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073014385379000_5.7.e002280.47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/tmi.12819","article-title":"Assessing healthcare quality using routine data: evaluating the performance of the National tuberculosis programme in South Africa","volume":"22","author":"McLaren","year":"2017","journal-title":"Trop Med Int Health"},{"key":"2025073014385379000_5.7.e002280.48","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0696"},{"key":"2025073014385379000_5.7.e002280.49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5588\/pha.18.0028","article-title":"Has the utilisation of Xpert\u00ae MTB\/RIF in Manicaland Province, Zimbabwe, improved with new guidance on whom to test?","volume":"8","author":"Jokwiro","year":"2018","journal-title":"Public Health Action"},{"key":"2025073014385379000_5.7.e002280.50","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0071"},{"key":"2025073014385379000_5.7.e002280.51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049898"},{"key":"2025073014385379000_5.7.e002280.52","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2382-0"},{"key":"2025073014385379000_5.7.e002280.53","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis920"},{"key":"2025073014385379000_5.7.e002280.54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103328"},{"key":"2025073014385379000_5.7.e002280.55","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2017.1290317","article-title":"Barriers to initiating tuberculosis treatment in sub-Saharan Africa: a systematic review focused on children and youth","volume":"10","author":"Sullivan","year":"2017","journal-title":"Glob Health Action"},{"key":"2025073014385379000_5.7.e002280.56","first-page":"2333794X1774414","article-title":"Time to drug-resistant tuberculosis treatment in a prospective South African cohort","volume":"4","author":"van de Water","year":"2017","journal-title":"Glob Pediatr Health"},{"key":"2025073014385379000_5.7.e002280.57","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2010.199505"},{"key":"2025073014385379000_5.7.e002280.58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5588\/ijtld.10.0691","article-title":"The social determinants of health: key to global tuberculosis control","volume":"15 Suppl 2","author":"Rasanathan","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073014385379000_5.7.e002280.59","unstructured":"CSDH . Closing the gap in a generation: health equity through action on the social determinants of health. final report of the Commission on social determinants of health. World Health Organization: Geneva, 2008: 256."},{"key":"2025073014385379000_5.7.e002280.60","doi-asserted-by":"publisher","DOI":"10.3201\/eid0204.960402"},{"key":"2025073014385379000_5.7.e002280.61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-9957-3-28","article-title":"Tackling the existing burden of infectious diseases in the developing world: existing gaps and the way forward","volume":"3","author":"Bhutta","year":"2014","journal-title":"Infect Dis Poverty"},{"key":"2025073014385379000_5.7.e002280.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61228-8"},{"key":"2025073014385379000_5.7.e002280.63","doi-asserted-by":"publisher","DOI":"10.1177\/1757975912470062"},{"key":"2025073014385379000_5.7.e002280.64","unstructured":"WHO . Health in all policies: Helsinki statement. framework for country action, 2014."},{"key":"2025073014385379000_5.7.e002280.65","unstructured":"Organization, W.H . Gear up to end TB: introducing the end TB strategy. World Health Organization, 2015."},{"key":"2025073014385379000_5.7.e002280.66","unstructured":"World Health Organization, . Health in all policies: Helsinki statement. framework for country action, 2014."},{"key":"2025073014385379000_5.7.e002280.67","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-019-6720-6","article-title":"Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation","volume":"19","author":"Mpagama","year":"2019","journal-title":"BMC Public Health"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2019-002280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:39:07Z","timestamp":1753911547000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2019-002280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":67,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,2]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bmjgh-2019-002280"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2019-002280","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}